 | • レポートコード：MRC2012A8475 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、短腸症候群（SBS）治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。短腸症候群（SBS）治療薬の種類別市場規模（グルカゴン様ペプチド-2（GLP-2）、成長ホルモン、グルタミン、その他）、用途別市場規模（病院、診療所、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Sancilio Pharmaceuticals、Ardelyx、Takeda、OxThera、Emmaus Medical、Nutrinia、Naia Pharmaceuticals、Zealand Pharma、 ・地域別グローバル市場分析 2015年-2020年 ・短腸症候群（SBS）治療薬の北米市場（アメリカ、カナダ、メキシコ） ・短腸症候群（SBS）治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・短腸症候群（SBS）治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・短腸症候群（SBS）治療薬の南米市場（ブラジル、アルゼンチン） ・短腸症候群（SBS）治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：グルカゴン様ペプチド-2（GLP-2）、成長ホルモン、グルタミン、その他 ・用途別分析：病院、診療所、小売薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Short Bowel Syndrome (SBS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Short Bowel Syndrome (SBS) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Short Bowel Syndrome (SBS) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Short Bowel Syndrome (SBS) Drugs market has been segmented into
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other
By Application, Short Bowel Syndrome (SBS) Drugs has been segmented into:
Hospitals
Clinics
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Short Bowel Syndrome (SBS) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Short Bowel Syndrome (SBS) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Short Bowel Syndrome (SBS) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Short Bowel Syndrome (SBS) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Short Bowel Syndrome (SBS) Drugs Market Share Analysis
Short Bowel Syndrome (SBS) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Short Bowel Syndrome (SBS) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Short Bowel Syndrome (SBS) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Short Bowel Syndrome (SBS) Drugs are:
Merck
Sancilio Pharmaceuticals
Ardelyx
Takeda
OxThera
Emmaus Medical
Nutrinia
Naia Pharmaceuticals
Zealand Pharma
Among other players domestic and global, Short Bowel Syndrome (SBS) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Short Bowel Syndrome (SBS) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Short Bowel Syndrome (SBS) Drugs, with price, sales, revenue and global market share of Short Bowel Syndrome (SBS) Drugs in 2018 and 2019.
Chapter 3, the Short Bowel Syndrome (SBS) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Short Bowel Syndrome (SBS) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Short Bowel Syndrome (SBS) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Short Bowel Syndrome (SBS) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Short Bowel Syndrome (SBS) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Short Bowel Syndrome (SBS) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Overview of Global Short Bowel Syndrome (SBS) Drugs Market
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sancilio Pharmaceuticals
2.2.1 Sancilio Pharmaceuticals Details
2.2.2 Sancilio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sancilio Pharmaceuticals SWOT Analysis
2.2.4 Sancilio Pharmaceuticals Product and Services
2.2.5 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ardelyx
2.3.1 Ardelyx Details
2.3.2 Ardelyx Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ardelyx SWOT Analysis
2.3.4 Ardelyx Product and Services
2.3.5 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 OxThera
2.5.1 OxThera Details
2.5.2 OxThera Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 OxThera SWOT Analysis
2.5.4 OxThera Product and Services
2.5.5 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Emmaus Medical
2.6.1 Emmaus Medical Details
2.6.2 Emmaus Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Emmaus Medical SWOT Analysis
2.6.4 Emmaus Medical Product and Services
2.6.5 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Nutrinia
2.7.1 Nutrinia Details
2.7.2 Nutrinia Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Nutrinia SWOT Analysis
2.7.4 Nutrinia Product and Services
2.7.5 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Naia Pharmaceuticals
2.8.1 Naia Pharmaceuticals Details
2.8.2 Naia Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Naia Pharmaceuticals SWOT Analysis
2.8.4 Naia Pharmaceuticals Product and Services
2.8.5 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Zealand Pharma
2.9.1 Zealand Pharma Details
2.9.2 Zealand Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Zealand Pharma SWOT Analysis
2.9.4 Zealand Pharma Product and Services
2.9.5 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.4 France Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.5 India Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Short Bowel Syndrome (SBS) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2015-2020)
11 Global Short Bowel Syndrome (SBS) Drugs Market Segment by Application
11.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Short Bowel Syndrome (SBS) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Short Bowel Syndrome (SBS) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.2 Europe Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.4 South America Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025)
12.3 Short Bowel Syndrome (SBS) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Type (2021-2025)
12.4 Short Bowel Syndrome (SBS) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Short Bowel Syndrome (SBS) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Short Bowel Syndrome (SBS) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Short Bowel Syndrome (SBS) Drugs Major Business
Table 9. Merck Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Short Bowel Syndrome (SBS) Drugs Product and Services
Table 12. Merck Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sancilio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Major Business
Table 15. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Sancilio Pharmaceuticals SWOT Analysis
Table 17. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
Table 18. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Ardelyx Basic Information, Manufacturing Base and Competitors
Table 20. Ardelyx Short Bowel Syndrome (SBS) Drugs Major Business
Table 21. Ardelyx Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Ardelyx SWOT Analysis
Table 23. Ardelyx Short Bowel Syndrome (SBS) Drugs Product and Services
Table 24. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Takeda Basic Information, Manufacturing Base and Competitors
Table 26. Takeda Short Bowel Syndrome (SBS) Drugs Major Business
Table 27. Takeda Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Takeda SWOT Analysis
Table 29. Takeda Short Bowel Syndrome (SBS) Drugs Product and Services
Table 30. Takeda Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. OxThera Basic Information, Manufacturing Base and Competitors
Table 32. OxThera Short Bowel Syndrome (SBS) Drugs Major Business
Table 33. OxThera Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 34. OxThera SWOT Analysis
Table 35. OxThera Short Bowel Syndrome (SBS) Drugs Product and Services
Table 36. OxThera Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Emmaus Medical Basic Information, Manufacturing Base and Competitors
Table 38. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Major Business
Table 39. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Emmaus Medical SWOT Analysis
Table 41. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product and Services
Table 42. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Nutrinia Basic Information, Manufacturing Base and Competitors
Table 44. Nutrinia Short Bowel Syndrome (SBS) Drugs Major Business
Table 45. Nutrinia Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Nutrinia SWOT Analysis
Table 47. Nutrinia Short Bowel Syndrome (SBS) Drugs Product and Services
Table 48. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Naia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Major Business
Table 51. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Naia Pharmaceuticals SWOT Analysis
Table 53. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product and Services
Table 54. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Zealand Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Major Business
Table 57. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Zealand Pharma SWOT Analysis
Table 59. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product and Services
Table 60. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Short Bowel Syndrome (SBS) Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 62. Global Short Bowel Syndrome (SBS) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Short Bowel Syndrome (SBS) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 64. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Regions (2015-2020)
Table 65. Global Short Bowel Syndrome (SBS) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Short Bowel Syndrome (SBS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 67. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries (2015-2020)
Table 68. North America Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2015-2020)
Table 70. Europe Short Bowel Syndrome (SBS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 71. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries (2015-2020)
Table 72. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 74. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Short Bowel Syndrome (SBS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 77. South America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries (2015-2020)
Table 78. South America Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 81. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2015-2020)
Table 84. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 85. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Type (2015-2020)
Table 86. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2015-2020) (USD Million)
Table 87. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2015-2020)
Table 88. Global Short Bowel Syndrome (SBS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 89. Global Short Bowel Syndrome (SBS) Drugs Sales Share by Application (2015-2020)
Table 90. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 91. Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Regions (2021-2025)
Table 92. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 93. Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Type (2021-2025)
Table 94. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Application (2021-2025)
Table 95. Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Short Bowel Syndrome (SBS) Drugs Picture
Figure 2. Global Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Type in 2019
Figure 3. Glucagon-Like Peptide-2 (GLP-2) Picture
Figure 4. Growth Hormone Picture
Figure 5. Glutamine Picture
Figure 6. Other Picture
Figure 7. Short Bowel Syndrome (SBS) Drugs Sales Market Share by Application in 2018
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Global Short Bowel Syndrome (SBS) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Short Bowel Syndrome (SBS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Short Bowel Syndrome (SBS) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Short Bowel Syndrome (SBS) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries in 2018
Figure 48. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Regions 2019
Figure 64. China Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries in 2019
Figure 71. South America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global Short Bowel Syndrome (SBS) Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales Short Bowel Syndrome (SBS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
短腸症候群（SBS）治療薬の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…- 短腸症候群（SBS）の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 短腸症候群の世界市場（～2026年） Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition…
- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- アスペルガー症候群治療薬の世界市場（～2026年） The Asperger syndrome is a type of developmental disorders known as Autistic Spectrum Disorder (ASD). These disorders initiate in childhood and stay with individuals until their adult life. Children with the Asperger syndrome function better than those with autism, and they have normal intelligence …